The nucleic acid based gene therapy global market report 2024 from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.
Nucleic Acid Based Gene Therapy Market, 2024 report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.
Market Size –
The nucleic acid based gene therapy market size has grown strongly in recent years. It will grow from $0.75 billion in 2023 to $0.82 billion in 2024 at a compound annual growth rate (CAGR) of 9.6%. The growth in the historic period can be attributed to growing understanding of human genetics, growing demand for personalized medicine, expanding pipeline of gene therapy products, growing government support for gene therapy, genetic disorders, cancer therapy.
The nucleic acid based gene therapy market size is expected to see rapid growth in the next few years. It will grow to $1.2 billion in 2028 at a compound annual growth rate (CAGR) of 10.1%. The growth in the forecast period can be attributed to expanding indications, increased funding, patient advocacy and awareness, growing investment in gene therapy research and development, expanding scope of gene therapy applications, rare diseases. Major trends in the forecast period include ex vivo gene editing, advances in in vivo gene editing, combination therapies, targeted delivery systems, gene editing for rare diseases, non-viral vectors.
Order your report now for swift delivery @
Scope Of Nucleic Acid Based Gene Therapy Market
The Business Research Company’s reports encompass a wide range of information, including:
1. Market Size (Historic and Forecast): Analysis of the market’s historical performance and projections for future growth.
2. Drivers: Examination of the key factors propelling market growth.
3. Trends: Identification of emerging trends and patterns shaping the market landscape.
4. Key Segments: Breakdown of the market into its primary segments and their respective performance.
5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.
6. Macro Economic Factors: Assessment of broader economic elements impacting the market.
Nucleic Acid Based Gene Therapy Market Overview
Market Drivers –
Rising financial support by the government and the companies is projected to drive the demand for nucleic acid-based gene therapy. Nucleic acid therapeutics are analogs of naturally occurring acids or proteins responsible for genetic expression. The traditional therapies do not have any cure for the treatment of diseases such as cystic fibrosis, hemophilia, sickle cell anemia, thalassemia, and diabetes. Genetic profiling and molecular target identification form the backbone of these classes of drugs. Nucleic acid medication has greater potential for the treatment of these diseases, as they target the genetic basis of diseases and have a permanent cure. Rising financial support by the government and the companies dealing in the market for gene therapy is expected to contribute to increasing the demand for nucleic acid-based gene therapy market. For instance, in August 2022, National Institute of Health (NIH) announced investment of $34 million annually for upcoming 5 years to develop HIV treatment research. The government support for gene therapies will contribute to the growth of the nucleic acid based gene therapy market.
Market Trends –
Major companies operating in the nucleic acid drugs market are developing innovative drugs such as Casimersen to drive revenues in the market. Casimersen is an ASO indicated for the treatment of DMD in patients with a confirmed mutation amenable to exon 45 skipping. For instance, in February 2021, Sarepta Therapeutics Inc., a US-based biotechnology company launched Casimersen (Amondys 45) approved by the Food and Drug Administration, a US-based government agency. This indication is based on a statistically significant increase in dystrophin production in skeletal muscle observed in patients treated with AMONDYS 45, and predicted a clinical benefit for those patients who are exon 45 amenable.
The nucleic acid based gene therapy market covered in this report is segmented –
1) By Technology: Anti-Sence and Anti-Gene, Short Inhibitory Sequences, Gene Transfer Therapy, Nucleoside Analogs, Ribozymes, Aptamers, Other Technologies
2) By Application: Oncology, Muscular Dystrophy/ Muscular Disorders, Rare Diseases
3) By End User: Hospitals And Clinics, Academic And Research Institutes
Get an inside scoop of the nucleic acid based gene therapy market, Request now for Sample Report @
Regional Insights –
North America was the largest region in the nucleic acid-based gene therapy market in 2023. Western Europe was the second-largest region in the nucleic acid-based gene therapy market report. The regions covered in the nucleic acid based gene therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
Key Companies –
Major companies operating in the nucleic acid based gene therapy market include Celsion Corporation, Wave Life Sciences, Imugene Ltd., Caperna LLC, Phylogica Limited, Protagonist Therapeutics Inc., Benitec Biopharma Ltd., EGEN, BioMedica, Transgene SA, Copernicus Therapeutics Inc., 4D Molecular Therapeutics Inc., Abeona Therapeutics Inc., Alnylam Pharmaceuticals Inc., Amgen Inc., Beam Therapeutics Inc., BioNTech SE, Bluebird Bio Inc., CRISPR Therapeutics AG, Editas Medicine Inc., Genevant Sciences Inc., Homology Medicines Inc., Intellia Therapeutics Inc., Ionis Pharmaceuticals Inc., MaxCyte Inc., Moderna Inc., Novartis International AG, Orchard Therapeutics plc, Precision BioSciences Inc., REGENXBIO Inc.
Table of Contents
1. Executive Summary
2. Nucleic Acid Based Gene Therapy Market Report Structure
3. Nucleic Acid Based Gene Therapy Market Trends And Strategies
4. Nucleic Acid Based Gene Therapy Market – Macro Economic Scenario
5. Nucleic Acid Based Gene Therapy Market Size And Growth
…..
27. Nucleic Acid Based Gene Therapy Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
Twitter: https://twitter.com/tbrc_info
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
